Keywords: Hikma, First-half results 2010
Jordanian drugmaker Hikma posts strong first-half 2010 results
Article | 27 August 2010
Fast-growing Jordan-headquartered Hikma Pharmaceuticals (LSE: HIK; Nasdaq Dubai: HIK)has reported interim results for the six months ended June 30, 2010, showing ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
